Buprenorphine and naloxone are combined in medication-assisted treatment approaches for opioid use disorder (OUD). The combination is designed to support treatment by reducing opioid withdrawal symptoms and cravings while helping limit misuse. Increasing attention to opioid dependence treatment and expanding access to evidence-based therapies are supporting market development. Market Size and...